How strong is the human evidence
As Seen on CNN: You Cannot Ignore the GLP1 Effect A January 2026 CNN Smerconish segment featuring consumer behavior analyst Ali Furman laid it out clearly (video): People on these medications consume ~40% fewer calories and are spending about 5% less at quick-service restaurants. The GLP1 customer isnt eating out less theyre eating differently. Ali Furman, CNN Smerconish - Ali Furman, US Consumer Markets Industry Leader, PwC Furman shared that household penetration of GLP1s rose from 9% to 20% in 2025 , and with oral versions expected soon, usage will likely climb even further
Recent Findings Beyond weight reduction, GLP-1RAs have shown positive cardiovascular outcomes in patients with elevated ASCVD risk, heart failure with preserved ejection fraction, obstructive sleep apnea, blood pressure, and dyslipidemia
Days 1528: Still within manufacturer guidelines
Generally, the answer is yes